Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1

Abstract

Aim: Here, we aim to evaluate the chemopreventive efficacy of kava root extracts (KRE) in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice and investigate potential molecular targets of kavalactones, the main components of kava.

Methods: TRAMP mice were administrated with KRE formulated food for different periods of time, and then the incidences of high-grade prostatic intraepithelial neoplasia (HG-PIN) and adenocarcinomas and tumor burdens were compared between vehicle control and KRE food fed groups. In addition, the inhibitory effect of the KRE and kavalactones on monoamine oxidase A (MAO-A) and lysine-specific demethylase 1 (LSD1) enzyme activities were examined by commercially available inhibitor screening kits. Histone H3 lysine 9 dimethylation was also evaluated in prostate cancer cells and tumor tissues using Western blotting analysis.

Results: Dietary feeding of 0.3% and 0.6% KRE to TRAMP mice from ages of 6 weeks to 12 weeks inhibited HG-PIN by 43.5% and 59.7%, respectively, and prostate adenocarcinoma by 53.5% and 66.4%, respectively. In addition, 0.6% KRE fed TRAMP mice from ages of 6 weeks to 24 weeks exhibited a significant reduction of genitourinary weight (a surrogate of tumor burden) by 54.5% and reduced body weight gain. Furthermore, the KRE and kavalactones showed a significant inhibition of LSD1 and MAO-A enzyme activities.

Conclusion: Our results suggest that consumption of kava products through diet can delay prostate cancer development and progression and that kavalactones may be a new structure model for developing a potent dual inhibitor of LSD1 and MAO-A.

Keywords

Kava / chemoprevention / LSD1 / MAO-A

References

[1] Key Statistics for Prostate Cancer. Available from: https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html. [Last accessed on 3 Jun 2021]

[2] CarlssonS,AlvimR.Long-term outcomes of active surveillance for prostate cancer: the memorial sloan kettering cancer center experience.J Urol2020;203:1122-7 PMCID:PMC7480884

[3] GreggJR,ChapinBF.Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: an active surveillance cohort.Cancer2021;127:720-8

[4] SinghYN.Kava: an overview.J Ethnopharmacol1992;37:13-45

[5] SarrisJ,BousmanCA.Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.Aust N Z J Psychiatry2020;54:288-97

[6] SavageKM,ByrneGJ.Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.Trials2015;16:493 PMCID:PMC4630875

[7] SmithK.The effectiveness and safety of Kava Kava for treating anxiety symptoms: a systematic review and analysis of randomized clinical trials.Complement Ther Clin Pract2018;33:107-17

[8] SteinerGG.The correlation between cancer incidence and kava consumption.Hawaii Med J2000;59:420-2

[9] LiX,XuX.Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice.PLoS One2012;7:e31213 PMCID:PMC3276576

[10] TangSN,JiangP.Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich kava fraction.Mol Carcinog2016;55:2291-303 PMCID:PMC6518389

[11] LiuZ,LiX.Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.Cancer Prev Res (Phila)2013;6:1365-75 PMCID:PMC3873822

[12] LeitzmanP,BalboS.Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice.Cancer Prev Res (Phila)2014;7:86-96 PMCID:PMC3888881

[13] SupramaniamR,TraceyE. Cancer in New South Wales Migrants 1991 to 2001. Available from: https://www.cancercouncil.com.au/wp-content/uploads/2010/09/A-Pg-1-23-Intro.pdf. [Last accessed on 3 Jun 2021]

[14] ShibuyaK,Boschi-PintoC,MurrayCJ.Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000.BMC Cancer2002;2:37 PMCID:PMC149364

[15] LiX,TippinM.Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.Cell Commun Signal2019;17:25 PMCID:PMC6423783

[16] LiX,ZhangS.Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.Oncotarget2015;6:41809-24 PMCID:PMC4747190

[17] ShappellSB,RobertsRL.Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.Cancer Res2004;64:2270-305

[18] ZhengYC,MaJL.Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.J Med Chem2013;56:8543-60 PMCID:PMC3881423

[19] PrinslooD,PetzerA.Monoamine oxidase inhibition by kavalactones from kava (piper methysticum).Planta Med2019;85:1136-42

[20] WangK,YehS.The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.Nat Commun2020;11:2689 PMCID:PMC7264333

[21] WuJB,LiX.Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.J Clin Invest2014;124:2891-908 PMCID:PMC4071401

[22] ZiX.Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.Cancer Res2005;65:3479-86

[23] PhamV,LeVX.Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy.Mol Carcinog2020;59:193-201 PMCID:PMC6946862

[24] ZhaoH,ChenZ,PeehlDM.Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells.Differentiation2008;76:820-30 PMCID:PMC2760409

[25] SehrawatA,WangY.LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.Proc Natl Acad Sci U S A2018;115:E4179-88 PMCID:PMC5939079

[26] MetzgerE,YinN.LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.Nature2005;437:436-9